Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05551975 · ClinicalTrials.gov registry record · NA
Preterm Infants Fed a Human Milk Fortifier
A NA study, sponsored by Abbott Nutrition.
- Not yet
- Registry status
- NA
- Development phase
- 321
- Enrollment target
NCT05551975: Clinical Trial NA study, sponsored by Abbott Nutrition.
NCT05551975 is a NA study that has not yet begun recruiting, run by Abbott Nutrition. The registered enrollment target is 321 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05551975, a NA study, has not yet begun recruiting, sponsored by Abbott Nutrition.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 321 participants
- Enrollment target
Study Summary
This is a double-blind, randomized, multi-center, controlled, parallel study to evaluate the growth and tolerance of preterm infants fed human milk fortifier (HMF).
Primary Outcome
Weight gain per day
Interventions
- OTHER Control Product
- OTHER Experimental Product 1
- OTHER Experimental Product 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 321 participants |
| Start Date | 2024-09 |
| Est. Completion | 2028-01 |
| Phase | NA |
What is known before NCT05551975 opens enrollment
NCT05551975 is an interventional study that assigns participants to a tested intervention. The registered 321 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower).
The record links to 0 conditions, and to 3 interventions - of which Control Product is the first listed.
NCT05551975 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05551975 about?
NCT05551975 is a clinical study titled "Preterm Infants Fed a Human Milk Fortifier". This is a double-blind, randomized, multi-center, controlled, parallel study to evaluate the growth and tolerance of preterm infants fed human milk fortifier (HMF).
What is the current status of trial NCT05551975?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 321 participants. The study started on 2024-09. Estimated completion is 2028-01.
What interventions are being tested in trial NCT05551975?
The interventions under investigation include: Control Product (OTHER), Experimental Product 1 (OTHER), Experimental Product 2 (OTHER).
Who is sponsoring clinical trial NCT05551975?
This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05551975's enrollment target sits among peer trials
321 315th of 2000 higher than 1,686 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03715933 · 321 participants · Phase 1
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
- NCT05922878 · 321 participants · Phase 2
Study of ALTO-300 in MDD
- NCT04090359 · 322 participants · Phase 4
Dual Mobility Acetabular Cups in Revision TJA
- NCT04924075 · 322 participants · Phase 2
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia